The Food and Drug Administration in the US has approved immunotherapy as a treatment to mitigate the risk of allergic reactions that may occur, including anaphylaxis, after accidental exposure to peanut in patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. To see the press release issued by the American Academy […]